Senti Biosciences, Inc.SNTINASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank84
3Y CAGR+0.7%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+0.7%/yr
Quarterly compound
Percentile
P84
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 28.81% |
| Q2 2025 | 5.56% |
| Q1 2025 | -3.96% |
| Q4 2024 | -71.82% |
| Q3 2024 | 5.74% |
| Q2 2024 | 28.66% |
| Q1 2024 | -66.13% |
| Q4 2023 | 59.15% |
| Q3 2023 | 0.62% |
| Q2 2023 | 23.97% |
| Q1 2023 | -30.06% |
| Q4 2022 | 27.93% |
| Q3 2022 | 28.21% |
| Q2 2022 | -94.40% |
| Q1 2022 | -9.29% |
| Q4 2021 | -63.87% |
| Q3 2021 | 32.78% |
| Q2 2021 | 0.00% |
| Q1 2021 | 100.00% |
| Q4 2020 | 0.00% |